MoneyWorks4Me

Ajanta Pharma informs about Press release

24 Aug 2015 Evaluate

Ajanta Pharma has informed about a Press Release date August 24, 2015 titled ‘Fortune India presents award to Ajanta Pharma’.

The above information is a part of company’s filings submitted to BSE.

 

Ajanta Pharma Share Price

3550.00 9.30 (0.26%)
28-Aug-2026 12:21 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1915.65
Dr. Reddys Labs. 1176.20
Cipla 1412.40
Lupin 2167.60
Zydus Lifesciences 1178.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: